Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study

M.T. Voso, G. Leone, A. Piciocchi, L. Fianchi, S. Santarone, A. Candoni, M. Criscuolo, A. Masciulli, E. Cerqui, A. Molteni, C. Finelli, M. Parma, A. Poloni, A.M. Carella, F. Spina, A. Cortelezzi, F. Salvi, E.P. Alessandrino, A. Rambaldi, S. Sica

Research output: Contribution to journalArticle

Cite this

Voso, M. T., Leone, G., Piciocchi, A., Fianchi, L., Santarone, S., Candoni, A., Criscuolo, M., Masciulli, A., Cerqui, E., Molteni, A., Finelli, C., Parma, M., Poloni, A., Carella, A. M., Spina, F., Cortelezzi, A., Salvi, F., Alessandrino, E. P., Rambaldi, A., & Sica, S. (2017). Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study. Annals of oncology : official journal of the European Society for Medical Oncology, 28(7), 1547-1553. https://doi.org/10.1093/annonc/mdx154